Enhanc3D Genomics

Enhanc3D Genomics operates the GenLink™ 3D multi-omics platform to measure genome folding and regulate gene function. The company integrates primary human cell data to identify therapeutic targets and causal biological networks for drug development. Their internal programs focus on autoimmune indications, while also providing discovery services to external pharmaceutical partners.